Immucor Forms Joint Venture with Kainos
TM Capital assisted Immucor, Inc. (NASDAQ) in forming a joint venture for distribution of Immucor’s products in Japan with Kainos Laboratories, Inc.
TM Capital assisted Immucor, Inc. (NASDAQ) in forming a joint venture for distribution of Immucor’s products in Japan with Kainos Laboratories, Inc.
TM Capital served as exclusive financial advisor to Nomura Research Institute (TYO: 4307) in its acquisition of Brierley+Partners
TM Capital completed the sale by Reckitt & Colman plc (LSE) of its Glamorene® product lines to Joh. A. Benckiser GmbH
TM Capital advised leading global-IT services company AppLabs Technologies in its cross-border acquisition of IS Integration
TM Capital served as exclusive financial advisor to Core Services Corporation in its sale to Syntax Systems, a portfolio company of Novacap
TM Capital assisted Frequency Electronics, Inc. (AMEX) in its strategic acquisition of Gillam s.a. of Belgium
TM Capital assisted Jennifer Convertibles in reorganizing and emerging from Chapter 11 through a confirmed Plan of Reorganization
TM Capital served as a financial advisor to Canadian Hospital Specialties, a portfolio company of Cortec Group, in its sale to Flexpoint Ford
TM Capital and its Swiss M&A International Inc. partner, Binder Corporate Finance, advised Datamars SA in the sale of a majority ownership stake of the Company to a group of private equity investors
TM Capital served as exclusive financial advisor to founder-owned Time-Cap Labs, Inc. in its sale to Marksans Pharma Limited (BSE:524404), headquartered in Mumbai, India